Merck opens manufacturing facility in North Carolina

Merck opens manufacturing facility in North Carolina amid Trump's tariff threats
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.
Merck opens vaccine manufacturing facility in North Carolina
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. Dru
Merck opens $1 billion addition in north Durham to boost production of popular vaccine
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.
Merck opens $1 billion vaccine manufacturing plant, expanding Durham site
Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug giant announced Tuesday.
Drugmaker Merck opens state-of-art $1B facility to manufacture HPV Gardasil, other vaccines
DURHAM, N.C. (WTVD) -- Drugmaker Merck announced Tuesday the opening of a new $1 billion vaccine manufacturing facility in North Durham. The plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the site as a whole continues to produce vaccines against measles, mumps, rubella, and chickenpox, among other illnesses.
Merck opens $1B vaccine plant in North Carolina
Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S.
Merck opens $1B Gardasil manufacturing facility in North Carolina
At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.
Drugmaker Merck opens state-of-the-art $1B facility in Durham
The new plant will manufacture the HPV vaccines and continue production on others.
The Business Journals2d
Merck completes $1B North Carolina expansion — more growth on the way
A global health care company is growing its footprint in North Carolina with a $1 billion investment. Merck (NYSE: MRK) has opened a new 225,000-square-foot vaccine manufacturing facility in ...
Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Merck scores victory in Gardasil lawsuits as judge questions evidence
A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding ...
Fierce Pharma2d
Merck defeats claims it should have added safety warnings to Gardasil's label, knocking out 200-plus lawsuits
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...